文献速递糖尿病

临床1型糖尿病诊断时单一胰岛自身抗体阳性与较大年龄及胰岛素抵抗相关

Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该研究基于T1D TrialNet研究的横断面分析,纳入786例自身抗体阳性亲属中进展为临床(3期)1型糖尿病且诊断前后有自身抗体数据者。诊断时单一自身抗体阳性见于119例(15.1%),与较大年龄、较高C肽指标、较高稳态模型胰岛素抵抗评估及较低T1D Index60显著相关(均P<0.03),校正BMI后差异减弱。结论认为单一自身抗体阳性与较大年龄及可能由BMI升高介导的胰岛素抵抗相关,提示疾病发病机制异质性。

要点

  • 诊断时单一自身抗体阳性占15.1%,以GAD65为主(72%)。
  • 单一自身抗体阳性与较大年龄、较高C肽及胰岛素抵抗指标相关(均P<0.03)。
  • 校正BMI后上述代谢差异减弱,提示BMI可能介导该关联。

核心结论

  • 与多种自身抗体阳性相比,3期1型糖尿病诊断时单一自身抗体阳性与较大年龄及可能由BMI升高介导的胰岛素抵抗相关,提示疾病发病机制异质性。

研究设计与样本

  • T1D TrialNet研究的横断面分析,纳入自身抗体阳性且进展为3期1型糖尿病、诊断前后有自身抗体数据的亲属786例(47.4%男性,79.9%非西班牙裔白人),诊断时中位年龄12.4岁(范围1.4-58.6岁)。

主要发现

  • 诊断时单一自身抗体阳性见于119例(15.1%),其中GAD65占72%、微量胰岛素抗体检测占13%、胰岛素瘤相关抗原2占11%、胰岛细胞抗体占1%、锌转运体8(ZnT8)自身抗体占3%。
  • 单一自身抗体阳性与较大年龄、较高C肽指标(空腹、曲线下面积、2小时及口服葡萄糖耐量试验早期反应)、较高稳态模型胰岛素抵抗评估及较低T1D Index60显著相关(均P<0.03)。
  • 校正年龄后2小时C肽仍具统计学差异,但控制BMI后差异减弱。
  • 性别、种族、族裔、人类白细胞抗原DR3-DQ2和/或DR4-DQ8、BMI分类及血糖指标与单一自身抗体阳性无显著关联。

临床怎么用

  • 作者认为这些差异可能与1型糖尿病的预防和治疗相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Multiple islet autoantibody positivity usually precedes clinical (stage 3) type 1 diabetes (T1D). OBJECTIVE: To test the hypothesis that individuals who develop stage 3 T1D with only a single autoantibody have unique metabolic differences. DESIGN: Cross-sectional analysis of participants in the T1D TrialNet study. SETTING: Autoantibody-positive relatives of individuals with stage 3 T1D. PARTICIPANTS: Autoantibody-positive relatives who developed stage 3 T1D (at median age 12.4 years, range = 1.4-58.6) and had autoantibody data close to clinical diagnosis (n = 786, 47.4% male, 79.9% non-Hispanic white). MAIN OUTCOME MEASURES: Logistic regression modeling was used to assess relationships between autoantibody status and demographic, clinical, and metabolic characteristics, adjusting for potential confounders and correcting for multiple comparisons. RESULTS: At diagnosis of stage 3 T1D, single autoantibody positivity, observed in 119 (15.1%) participants (72% GAD65, 13% microinsulin antibody assay, 11% insulinoma-associated antigen 2, 1% islet cell antibody, 3% autoantibodies to zinc transporter 8 [ZnT8]), was significantly associated with older age, higher C-peptide measures (fasting, area under the curve, 2-hour, and early response in oral glucose tolerance test), higher homeostatic model assessment of insulin resistance, and lower T1D Index60 (all P < 0.03). While with adjustment for age, 2-hour C-peptide remained statistically different, controlling for body mass index (BMI) attenuated the differences. Sex, race, ethnicity, human leukocyte antigen DR3-DQ2, and/or DR4-DQ8, BMI category, and glucose measures were not significantly associated with single autoantibody positivity. CONCLUSIONS: Compared with multiple autoantibody positivity, single autoantibody at diagnosis of stage 3 T1D was associated with older age and insulin resistance possibly mediated by elevated BMI, suggesting heterogeneous disease pathogenesis. These differences are potentially relevant for T1D prevention and treatment.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Redondo MJ, Sosenko J, Libman I, et al. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance. J Clin Endocrinol Metab. 2020. PMID: 31867614. doi:10.1210/clinem/dgz296

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。